Sam Altman-Backed Retro Biosciences Raises $1B to Extend Human Lifespan

OpenAI’s Sam Altman is backing Retro Biosciences’ ambitious $1B fundraising round to develop longevity drugs targeting diseases like Alzheimer’s. The Billion-Dollar Bet on Longevity: Sam Altman’s Vision for Extending Life … Read More

Changpeng Zhao’s Bold Comeback: Doubling Down on Blockchain, AI, and Biotech Investments Post-Imprisonment

Changpeng Zhao, former CEO of Binance, has made a significant comeback following a four-month jail sentence. He is now directing his investments toward blockchain, AI, and biotechnology, aiming to make … Read More